News

29 May 2020

EIN Newsdesk: US FDA approves 4DMedical’s new respiratory diagnostic tool, XV Technology

Woodland Hills, California Tuesday, May 26, 2020, 10:00 Hrs  [IST] Australian medical technology company, 4DMedical has received clearance from the US Food & Drug Administration to market its XV Technology, a patented four-dimensional lung imaging process that rapidly and automatically analyses any functional lung impairment from a single X-ray. 4DMedical’s US operations are based in Woodland […]

READ POST
29 May 2020

MassDevice.com: FDA clears 4D Medical’s lung imaging technology

MAY 26, 2020 BY SEAN WHOOLEY 4DMedical announced that it received FDA clearance for its XV Technology for analyzing functional lung impairment from a single X-ray. Australia-based 4DMedical (formerly 4DX), which has a U.S. base in Woodland Hills, Calif., designed the XV Technology as a four-dimensional lung imaging process in the form of a software-as-a-service (Saas) diagnostic tool. […]

READ POST
28 May 2020

TMG Pulse: 4DMedical’s Lung Imaging Technology Receives FDA Clearance as COVID-19 Intensifies Global Focus on Respiratory Health

Released on May 25, 2020 WOODLAND HILLS, Calif., May 25, 2020 /PRNewswire/ — 4DMedical, an Australian medical technology company specializing in medical imaging innovation software, announced today it has received clearance from the U.S. Food & Drug Administration to market its XV Technology™,  a patented four-dimensional lung imaging  process that rapidly and automatically analyses any functional  lung impairment […]

READ POST
28 May 2020

Aunt Minnie: 4DMedical gets FDA clearance for lung analysis software

By AuntMinnie.com staff writers May 27, 2020 -- Medical image analysis software developer 4DMedical (formerly 4Dx) has received U.S. Food and Drug Administration (FDA) clearance for XV Technology, a software application that provides 4D analysis of functional lung impairment from a fluoroscopy exam.Available as a software-as-a-service through a cloud subscription, XV Technology can be implemented [...]
READ POST
28 May 2020

T-Town Media.com: 4DMedical’s Lung Imaging Technology Receives FDA Clearance as COVID-19 Intensifies Global Focus on Respiratory Health

WOODLAND HILLS, Calif., May 25, 2020 /PRNewswire/ — 4DMedical, an Australian medical technology company specializing in medical imaging innovation software, announced today it has received clearance from the U.S. Food & Drug Administration to market its XV Technology™,  a patented four-dimensional lung imaging  process that rapidly and automatically analyses any functional  lung impairment from a single X-ray. 4DMedical’s […]

READ POST
27 May 2020

NewsBreak.com: 4DMedical’s Lung Imaging Technology Receives FDA Clearance as COVID-19

4DMedical, an Australian medical technology company specializing in medical imaging innovation software, announced it has received clearance from the U.S. Food & Drug Administration to market its XV Technology™, a patented four-dimensional lung imaging process that rapidly and automatically analyses any functional lung impairment from a single X-ray. 4DMedical’s U.S. operations are based in Woodland […]

READ POST
27 May 2020

Verdict Medical Devices: US FDA clears 4DMedical’s lung imaging technology

26 MAY 2020 4DMedical’s XV Technology automatically analyses any functional lung impairment from a single X-ray. Credit: Stillwaterising / Wiki Commons. The US Food and Drug Administration (FDA) has granted regulatory clearance to 4DMedical to market its four-dimensional lung imaging process XV Technology. The technology is a software-as-a-service (SaaS) diagnostic tool available through secure cloud […]

READ POST
26 May 2020

Asian Hospital & Healthcare Management: 4DMedical’s Lung Imaging Technology Receives FDA Clearance as COVID-19 Intensifies Global Focus on Respiratory Health

TUESDAY, MAY 26, 2020 4DMedical, an Australian medical technology company specializing in medical imaging innovation software, announced today it has received clearance from the U.S. Food & Drug Administration to market its XV Technology™,  a patented four-dimensional lung imaging  process that rapidly and automatically analyses any functional  lung impairment from a single X-ray. 4DMedical’s U.S. […]

READ POST
26 May 2020

MJH Life Sciences, Diagnostic Imaging: FDA Awards Clearance to 4D Lung Imaging Software

  Written by: Whitney J. Palmer 4DMedical, an Australian-based medical innovation software company, announced Tuesday it has received 510(k) clearance from the U.S. Food & Drug Administration for its XV Technology™, a four-dimensional lung imaging process. According to a company statement, XV Technology™ can quickly and automatically analyze functional lung impairments from a single X-ray. […]

READ POST
26 May 2020

Smart Market News: 4DMedical’s Lung Imaging Technology Receives FDA Clearance as COVID-19 Intensifies Global Focus on Respiratory Health

“Our XV Technology™ is a valuable new respiratory diagnostic tool,” said 4DMedical founder and CEO, Andreas Fouras, Ph.D. “It provides critical information about the functional and structural state of a patient’s lungs in the treatment of illnesses such as COVID-19, asthma, chronic obstructive pulmonary disease, cystic fibrosis and lung cancer.” By Neha Pandey      4DMedical, […]

READ POST

Subscribe to our Newsletter

  • This field is for validation purposes and should be left unchanged.